BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34173325)

  • 1. Practice pattern variability among gastroenterologists in colorectal cancer surveillance and management of colorectal dysplasia in inflammatory bowel disease.
    Chan WPW; Tan YB; Shim HH; Kaltenbach T; Soetikno R
    J Dig Dis; 2021 Aug; 22(8):463-472. PubMed ID: 34173325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
    Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
    Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
    Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
    Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Biopsies Identify Larger Proportions of Patients With Colonic Neoplasia Undergoing High-Definition Colonoscopy, Dye Chromoendoscopy, or Electronic Virtual Chromoendoscopy.
    Gasia MF; Ghosh S; Panaccione R; Ferraz JG; Kaplan GG; Leung Y; Novak KL; Seow CH; Iacucci M
    Clin Gastroenterol Hepatol; 2016 May; 14(5):704-12.e4. PubMed ID: 26804384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the real-world challenges of dysplasia surveillance in inflammatory bowel disease: a retrospective cohort study in a tertiary health network.
    Elford AT; Hirsch R; McKay OM; Browne M; Moore GT; Bell S; Swan M
    Intern Med J; 2024 Jan; 54(1):96-103. PubMed ID: 37093665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy.
    Coelho-Prabhu N; Bruining DH; Faubion WA; Kane SV; Kisiel JB; Papadakis KA; Pardi DS; Raffals LE; Schroeder KW; Tremaine WJ; Fruth K; Harmsen WS; Loftus EV
    Inflamm Bowel Dis; 2021 Apr; 27(5):594-602. PubMed ID: 32529198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.
    Shah SA; Rubin DT; Farraye FA
    Curr Gastroenterol Rep; 2014 Sep; 16(9):407. PubMed ID: 25113042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 10. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
    Clarke WT; Feuerstein JD
    World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
    Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
    Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Flynn AD; Valentine JF
    Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
    Marion JF; Waye JD; Present DH; Israel Y; Bodian C; Harpaz N; Chapman M; Itzkowitz S; Steinlauf AF; Abreu MT; Ullman TA; Aisenberg J; Mayer L;
    Am J Gastroenterol; 2008 Sep; 103(9):2342-9. PubMed ID: 18844620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer.
    El-Dallal M; Chen Y; Lin Q; Rakowsky S; Sattler L; Foromera J; Grossberg L; Cheifetz AS; Feuerstein JD
    Inflamm Bowel Dis; 2020 Aug; 26(9):1319-1329. PubMed ID: 32034916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal polyps in ulcerative colitis and Crohn's colitis.
    Fort Gasia M; Ghosh S; Iacucci M
    Minerva Gastroenterol Dietol; 2015 Dec; 61(4):215-22. PubMed ID: 26446684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromoendoscopy versus standard colonoscopy for detection of nonpolypoid dysplasia in patients with inflammatory bowel disease.
    Sekra A; Schauer C; Mills L; Vandal AC; Rose T; Lal D; Ogra R
    N Z Med J; 2018 Jul; 131(1478):32-38. PubMed ID: 30001304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of patients with inflammatory bowel disease.
    Yu JX; East JE; Kaltenbach T
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Definition Chromoendoscopy Superior to High-Definition White-Light Endoscopy in Surveillance of Inflammatory Bowel Diseases in a Randomized Trial.
    Alexandersson B; Hamad Y; Andreasson A; Rubio CA; Ando Y; Tanaka K; Ichiya T; Rezaie R; Schmidt PT
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2101-2107. PubMed ID: 32353535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
    Thomas T; Nair P; Dronfield MW; Mayberry JF
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases.
    Ten Hove JR; Mooiweer E; Dekker E; van der Meulen-de Jong AE; Offerhaus GJ; Ponsioen CY; Siersema PD; Oldenburg B
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):222-228.e2. PubMed ID: 27613257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.